Immunoassay utilizing trapping conjugate

Inventors

Esfandiari, Javanbakhsh

Assignees

Chembio Diagnostic Systems Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-9885710-B2

Patent

Publication Date

2018-02-06

Expiration Date


Abstract

Test devices are provided for determining the presence of a first ligand in a sample. In some embodiments depletion conjugates are used to deplete the ligands different from but related to the first ligands from the sample. In some embodiments, interim binding agents are used to enhance the test signal.

Core Innovation

The test device determines the presence of a first flu antibody in a liquid sample using distinct first and second sorbent strips that define separate migration paths. A marker conjugate moves along the first migration path and binds to the first flu antibody. Depletion molecules in the second migration path bind to a different but related second flu antibody before the sample reaches the test site.

The strips touch at a test site with an immobilized binding mechanism for the first flu antibody, while the second sample location is removed from the test site so the sample does not immediately wet it. This arrangement is described alongside reduced non-pandemic flu-A signals and preserved flu-B signals. The partial content does not include the background section, so the problem being solved is not explicitly described in patent.

Claims Coverage

The provided relevant claims identify one independent claim and four main inventive features concerning the separate migration paths, depletion molecules, test site, and delayed wetting.

Separate sorbent strips and migration paths

A first sorbent strip defines a first migration path and carries a marker conjugate adapted to bind to the first flu antibody. A distinct second sorbent strip defines a second migration path for the liquid sample.

Depletion molecules for a related flu antibody

Depletion molecules located on or in the second migration path include an immobilized ligand-binding element adapted to bind a second flu antibody that is different from but related to the first flu antibody.

Test site with an immobilized binding mechanism

A test site on or in at least one sorbent strip has an immobilized first-ligand binding mechanism. The first and second sorbent strips touch each other at the test site location.

Spaced second sample location

The second location for receiving the liquid sample is removed from the test site, such that the sample requires time to migrate to the test site and does not immediately wet it.

The independent claim combines two distinct sorbent-strip paths, depletion of a different but related flu antibody, a shared test site, and a spaced second sample location that delays wetting.

Stated Advantages

In influenza tests, H1/H3 depletion markedly reduces non-pandemic flu-A signals while preserving flu-B signals comparable to a standard dual-path device.

White latex particles can reduce visible background if conjugate migrates.

Additional embodiments use interim binding agents to enhance HIV p24 detection.

Documented Applications

Influenza tests that distinguish a first flu antibody from a different but related flu antibody, including the described flu-A and flu-B signal comparisons.

HIV p24 detection using additional embodiments with interim binding agents.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.